Literature DB >> 11258430

Effect of histological damage on long-term kidney transplant outcome.

B J Nankivell1, C A Fenton-Lee, D R Kuypers, E Cheung, R D Allen, P J O'Connell, J R Chapman.   

Abstract

BACKGROUND: Chronic renal allograft failure remains a major challenge to overcome. Factors such as donor quality, delayed graft function (DGF), acute rejection, and immunosuppression are known to affect long-term outcome, but their relationship to histological damage to graft outcome is unclear.
METHODS: Protocol kidney biopsies (n=112) obtained at 3 months after transplantation yielded 102 with adequate tissue. Histology was scored by the Banff schema, and compared with implantation biopsies (n=91), repeat 12-month histology (n=39), decline in serum creatinine and serial isotopic glomerular filtration rate, onset of chronic allograft nephropathy (CAN), and actuarial graft survival censored for death with a functioning graft.
RESULTS: At a median follow-up of 9.3 years, 20 patients had graft failure and 26 died with a functioning graft. Banff chronic nephropathy was present in 24% of 3-month biopsies, and was predicted by microvascular disease in the donor, cold ischemia, DGF, and acute vascular rejection (P<0.001). Acute glomerulitis at 3 months correlated with segmental glomerulosclerosis at 12 months, subsequent recurrent glomerulonephritis, and graft failure (P<0.01). Subclinical rejection at 3 months occurred in 29% of biopsies, correlated with prior acute rejection and HLA mismatch, and led to chronic histological damage by 12 months (r=0.25-0.67, P<0.05-0.001). Subclinical rejection, arteriolar hyalinosis, and tubulitis present at 3 months had resolved by 12 months. The 10-year survival rates for Banff chronic nephropathy were 90.4% for grade 0, 81.0% grade 1, and 57.9% for grades 2 or greater (P<0.01). Early tubulointerstitial damage at 3 months profoundly influenced graft survival beyond 10 years. CAN was predicted by kidney ischemia, 3-month chronic intimal vascular thickening, tubular injury, proteinuria, and late rejection. Chronic fibrointimal thickening of the small arteries and chronic interstitial fibrosis at 3 months independently predicted graft loss and decline in renal function (P<0.05-0.001).
CONCLUSIONS: Early transplant damage occurs in the tubulointerstitial compartment from preexisting donor kidney injury and discrete events such as vascular rejection and DGF. Subsequent chronic damage and graft failure reflect accumulated previous injury and chronic interstitial fibrosis, vascular impairment, subclinical rejection, and injury from late rejection. CAN may be conceptualized as the sequelae of incremental and cumulative damage to the transplanted kidney. The duration of graft survival is dependent and predicted by the quality of the transplanted donor kidney combined with the intensity, frequency, and irreversibility of these damaging insults.

Entities:  

Mesh:

Year:  2001        PMID: 11258430     DOI: 10.1097/00007890-200102270-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  47 in total

Review 1.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

2.  Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique.

Authors:  Vincent Vuiblet; Michael Fere; Cyril Gobinet; Philippe Birembaut; Olivier Piot; Philippe Rieu
Journal:  J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 10.121

3.  Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients.

Authors:  Ron Shapiro; Thomas E Starzl
Journal:  Pediatr Transplant       Date:  2006-11

4.  Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study.

Authors:  C Alfieri; A Regalia; G Moroni; D Cresseri; F Zanoni; M Ikehata; P Simonini; M P Rastaldi; G Tripepi; C Zoccali; C Chatziantoniou; Piergiorgio Messa
Journal:  J Nephrol       Date:  2019-01-10       Impact factor: 3.902

5.  C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Authors:  Mark Haas; Dorry L Segev; Lorraine C Racusen; Serena M Bagnasco; Jayme E Locke; Daniel S Warren; Christopher E Simpkins; Diane Lepley; Karen E King; Edward S Kraus; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

6.  Differentiation of alloreactive versus CD3/CD28 stimulated T-lymphocytes using Raman spectroscopy: a greater specificity for noninvasive acute renal allograft rejection detection.

Authors:  Kristian L Brown; Olena Y Palyvoda; Jagdish S Thakur; Sandra L Nehlsen-Cannarella; Omar R Fagoaga; Scott A Gruber; Gregory W Auner
Journal:  Cytometry A       Date:  2009-11       Impact factor: 4.355

7.  Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes.

Authors:  Maarten Naesens; Purvesh Khatri; Li Li; Tara K Sigdel; Matthew J Vitalone; Rong Chen; Atul J Butte; Oscar Salvatierra; Minnie M Sarwal
Journal:  Kidney Int       Date:  2011-08-31       Impact factor: 10.612

Review 8.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

9.  Donor ABCB1 variant associates with increased risk for kidney allograft failure.

Authors:  Jason Moore; Amy Jayne McKnight; Bernd Döhler; Matthew J Simmonds; Aisling E Courtney; Oliver J Brand; David Briggs; Simon Ball; Paul Cockwell; Christopher C Patterson; Alexander P Maxwell; Stephen C L Gough; Gerhard Opelz; Richard Borrows
Journal:  J Am Soc Nephrol       Date:  2012-10-11       Impact factor: 10.121

10.  Urine proteomics to detect biomarkers for chronic allograft dysfunction.

Authors:  Luís F Quintana; Amanda Solé-Gonzalez; Susana G Kalko; Elisenda Bañon-Maneus; Manel Solé; Fritz Diekmann; Alex Gutierrez-Dalmau; Joaquin Abian; Josep M Campistol
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.